CHANGES IN CYCLIN DEPENDENT KINASE INHIBITORS p21 AND p27 DURING THE CASTRATION INDUCED REGRESSION OF THE CWR22 MODEL OF PROSTATIC ADENOCARCINOMA

This publication has 13 references indexed in Scilit:

• Cyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß
  Published by Elsevier ,1997
• Regulation of prostatic growth and function by peptide growth factors
  The Prostate, 1996
• Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate Cancer
  Journal of Urology, 1996
• Cdk inhibitors: on the threshold of checkpoints and development
  Current Opinion in Cell Biology, 1994
• Expression of p160erbB-3 and p185erbB-2 in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma
  JNCI Journal of the National Cancer Institute, 1994
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
  Genes & Development, 1994
• Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor
  Journal of Clinical Endocrinology & Metabolism, 1993
• Expression of Transforming Growth Factor-β in the Rat Ventral Prostate during Castration-Induced Programmed Cell Death
  Molecular Endocrinology, 1989
• A stagewise rejective multiple test procedure based on a modified Bonferroni test
  Biometrika, 1988